Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urapidil in hypercholesterolemic hypertensive patients

L A Ferrara1, G Leonetti, R Fogari

  • 1Institute of Internal Medicine, Federico II University, Naples, Italy.

Blood Pressure. Supplement
|January 1, 1994
PubMed
Summary

Urapidil effectively lowered blood pressure (BP) in hypertensive patients with hypercholesterolemia. This study found urapidil to be a safe and effective treatment option for managing both conditions simultaneously.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat.

Journal of hypertension·2001
Same author

Transient but not sustained blood pressure increments by occupational noise. An ambulatory blood pressure measurement study.

Journal of hypertension·2001
Same author

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

Journal of hypertension·2001
Same author

Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study.

Journal of hypertension·2001
Same author

Impact of the Gubbio population study on community control of blood pressure and hypertension. Gubbio Study Research Group.

Journal of hypertension·2001
Same author

Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) study.

Journal of hypertension·2001

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Arterial hypertension and hyperlipidemia significantly increase cardiovascular disease risk.
  • Some antihypertensive drugs may positively impact lipid profiles.

Purpose of the Study:

  • To evaluate the effects of urapidil on blood pressure and plasma lipids in hypertensive patients with hypercholesterolemia.
  • To compare urapidil's efficacy against a placebo over six months.

Main Methods:

  • A double-blind, randomized study involving 49 patients with mild hypertension and hypercholesterolemia.
  • Patients were treated with either urapidil or a placebo for six months.
  • Blood pressure and serum lipid levels were monitored throughout the study.

Main Results:

Related Experiment Videos

  • Urapidil significantly decreased blood pressure from 159/99 mmHg to 152/90 mmHg.
  • No significant change in blood pressure was observed in the placebo group.
  • The difference in blood pressure reduction between the urapidil and placebo groups was statistically significant (p < 0.05).

    • Conclusions:

    • Urapidil demonstrated significant efficacy in reducing blood pressure in patients with co-existing hypertension and hypercholesterolemia.
    • Urapidil appears to be a safe and effective treatment option for this patient population.
    • Further research may explore urapidil's long-term effects on cardiovascular outcomes.